Statement from the Japanese Respiratory Society: Working diagnosis and initial management of COPD during the COVID-19 pandemic

Respir Investig. 2021 Jul;59(4):385-388. doi: 10.1016/j.resinv.2021.03.004. Epub 2021 Apr 6.

Abstract

The Japanese Respiratory Society (JRS) has recommended spirometry for the diagnosis of respiratory diseases. It is indispensable for the confirmation of airflow obstruction by spirometry in chronic obstructive pulmonary disease (COPD) diagnosis. However, the coronavirus disease 2019 (COVID-19) pandemic has made it difficult for many clinics to perform spirometry as it may lead to possible aerosol infections. Thus, the diagnosis of COPD, especially in the early stage, has become difficult. To overcome this situation, JRS issued a "Flowchart of Working Diagnosis and Management of COPD during the COVID-19 Pandemic". This flowchart may help physicians provisionally diagnose COPD patients without performing spirometry, offering them appropriate intervention even in epidemic and pandemic situations.

Keywords: COPD; COVID-19; Pandemic; Spirometry.

MeSH terms

  • Adrenergic beta-2 Receptor Agonists / therapeutic use
  • COVID-19*
  • Delayed-Action Preparations
  • Diagnostic Techniques, Respiratory System*
  • Drug Therapy, Combination
  • Early Diagnosis
  • Humans
  • Japan
  • Muscarinic Antagonists / therapeutic use
  • Pulmonary Disease, Chronic Obstructive / diagnosis*
  • Pulmonary Disease, Chronic Obstructive / therapy*
  • Pulmonary Medicine / organization & administration*
  • Societies, Medical / organization & administration*
  • Spirometry

Substances

  • Adrenergic beta-2 Receptor Agonists
  • Delayed-Action Preparations
  • Muscarinic Antagonists